Orodental Changes Associated with Hepatic Disorders and it’s Clinicopathological Implications

  • Surya Narayan Das Odisha, India
  • Lipsa Bhuyan Odisha, India
Keywords: Hepatic disorders, Liver diseases, Orodental manifestations

Abstract

Background: Hepatic complex can be vulnerable to numerous diseases ascribed to the intake of few drugs, alcohol, or infections which manifests itself in oral cavity.
Materials and Methods: The patients diagnosed as acute or chronic liver disease by clinical examination, liver function tests, and morphological examination which was selected. Detailed dental and oral examination was done and manifestations such as the presence of gingival bleeding, oral lichen planus, xerostomia, sialadenitis, stomatitis, periodontal disease, and others were noted. The data were then subjected to statistical analysis.
Results: Jaundice due to viral hepatitis (44.7%), alcoholic liver diseases (28%), alcoholic cirrhosis (18.7%), cirrhosis of liver (16%), hepatomegaly (14.7%), hepatic carcinoma (7.3%), and hepatitis B (6%) were the various liver disorders encountered. On oral examination, a significantly higher number of study subjects were detected with one or more oral abnormalities when compared to subjects (P ≤ 0.05). Oral manifestations include periodontitis, halitosis, xerostomia, bald tongue, fissured tongue, hyperpigmentation, candidiasis, and oral lichen planus.
Conclusion: The complex mechanism of liver and its susceptibility to a variety of dysfunction can not only have systemic but also many oral manifestations.

Author Biographies

Surya Narayan Das, Odisha, India

1Proffesor and HOD, Department of Oral and Maxillofacial Pathology, SCB Dental College and Hospital, Cuttack, 

Lipsa Bhuyan, Odisha, India

Lecture, Department of Oral and Maxillofacial Pathology, Kalinga Institute of Dental Sciences, KIIT, Bhubaneswar, 

References

1. Casamassimo PS, Flaitz CM, Hammersmith K, Sangvai S, Kumar A.
Recognizing the relationship between disorders in the oral cavity and
systemic disease. Pediatr Clin North Am 2018;65:1007-32.
2. Kalra A, Tuma F. Physiology, liver. In: Stat Pearls. Treasure Island, FL: Stat
Pearls Publishing; 2020.
3. Cruz-Pamplona M, Margaix-Muñoz M, Gracia Sarrión-Pérez MG. Dental
considerations in patients with liver disease. J Clin Exp Dent 2011;3:e127-
34.
Das and Bhuyan: Orodental Changes in Hepatic Disorders
137 International Journal of Scientific Study | June 2020 | Vol 8 | Issue 3
4. Olczak-Kowalczyk D, Krasuska-Sławińska E, Gozdowski D, Kowalczyk W,
Pawłowska J. Oral mucosa lesions and gingival bleeding can indicate the
progression of liver disease in children and adolescents aged two to 18
years. Acta Paediatr 2018;107:886-92.
5. Carrozzo M, Scally K. Oral manifestations of hepatitis C Virus infection.
World J Gastroenterol 2014;20:7534-43.
6. Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P. Oral conditions
associated with hepatitis C Virus infection. Saudi J Gastroenterol
2013;19:245-51.
7. Henderson L, Muir M, Mills PR, Spence E, Fox R, McCruden EA, et al.
Oral health of patients with hepatitis C Virus infection: A pilot study. Oral
Dis 2001;7:271-5.
8. Teshigawara K, Kakizaki S, Sohara N, Hashida T, Tomizawa Y, Sato K, et al.
Solitary mandibular metastasis as an initial manifestation of hepatocellular
carcinoma. Acta Med Okayama 2006;60:243-7.
9. Paraschiv C, Gavrilescu C, Cotea I, Esanu I, Ghiuru R, Munteanu D. Oral
manifestations in liver diseases. Rom J Oral Rehabil 2011;3:24-9.
10. Grønkjær LL. Periodontal disease and liver cirrhosis: A systematic review.
SAGE Open Med 2015;3:2050312115601122.
11. Novacek G, Plachetzky U, Potzi R, Lentner S, Slavicek R, Gangl A, et al.
Dental and periodontal disease in patents with cirrhosis-role of etiology of
liver disease. J Hepatol 1995;22:576-82.
12. Movin S. Relationship between periodontal disease and cirrhosis of the
liver in humans. J Clin Periodontol 1981;8:450-8.
13. Han P, Sun D, Yang J. Interaction between periodontitis and liver diseases.
Biomed Rep 2016;5:267-76.
14. Osborne BV. A nose for trouble. Br J Gen Pract 2012;62:652-3.
15. Han DH, Lee SM, Lee JG, Kim YJ, Kim JB. Association between viral
hepatitis B infection and halitosis. Acta Odontol Scand 2014;72:274-82.
16. Yu YH, Park YS, Kim SH, Son BK, Jun DW, Jo YJ, et al. Sialadenosis in a
patient with alcoholic fatty liver developing after heavy alcohol drinking.
Korean J Gastroentrol 2009;54:50-4.
17. Guggenheimer J, Close JM, Eghtesad B, Shay C. Characteristics of oral
abnormalities in liver transplant candidates. Int J Organ Transplant Med
2010;1:107-13.
18. Ramos-Casals M, Trejo O, García-Carrasco M, Font J. Therapeutic
management of extrahepatic manifestations in patients with chronic
hepatitis C Virus infection. Rheumatology (Oxford) 2003;42:818-28.
19. Grossmann SM, Teixeira R, de Oliveira GC, Gleber-Netto FO, Araújo FM,
Araújo FM, et al. Xerostomia, hyposalivation and sialadenitis in patients
with chronic hepatitis C are not associated with the detection of HCV RNA
in saliva or salivary glands. J Clin Pathol 2010;63:1002-7.
20. Grossmann SM, Teixeira R, de Oliveira GC, do Carmo MA. Detection of
HCV RNA in saliva does not correlate with salivary flow or xerostomia
in patients with chronic hepatitis C. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2010;109:851-6.
21. Nawito Z, Amin A, El-Fadl SA, El Einen KA. Sicca complex among
Egyptian patients with chronic hepatitis C Virus infection. Clin Rheumatol
2011;30:1299-304.
22. Giordano N, Amendola A, Papakostas P, Cipolli F, Agate VM, Battisti E,
et al. Immune and autoimmune disorders in HCV chronic liver disease:
Personal experience and commentary on literature. New Microbiol
2005;28:311-7.
23. Tsilika K, Tran A, Trucchi R, Pop S, Anty R, Cardot-Leccia N, et al.
Secondary hyperpigmentation during interferon alfa treatment for chronic
hepatitis C Virus infection. JAMA Dermatol 2013;149:675-7.
24. Sulka A, Simon K, Piszko P, Kalecińska E, Dominiak M. Oral mucosa
alterations in chronic hepatitis and cirrhosis due to HBV or HCV infection.
Bull Group Int Rech Sci Stomatol Odontol 2006;47:6-10.
25. Erdoğan A, Kansu L, Akkaya H. Hyperpigmentation of tongue associated
with hepatitis C treatment. Balkan Med J 2013;30:257-8.
26. Rojas G, Bravo L, Cordero K, Sepúlveda L, Elgueta L, Díaz JC, et al.
Integrity of the oral tissues in patients with solid-organ transplants. J
Transplant 2012;2012:603769.
27. Rebora A. Lichen planus and the liver. Int J Dermatol 1992;31:392-5.
28. Friedrich RE, Heiland M, El-Moawen A, Dogan A, von Schrenck T,
Loning T. Oral lichen planus in patients with chronic liver diseases.
Infection 2003;31:383-6.
29. Figueiredo LC, Carrilho FJ, de Andrade HF Jr., Migliari DA. Oral lichen
planus and hepatitis C Virus infection. Oral Dis 2002;8:42-6.
30. Gandolfo S, Gallo V, Carbone M, Zulian P, Carrozzo M. Oral lichen
planus and liver pathology. I. The prevalence of liver damage in a
case load of 96 patients with oral lichen planus. Minerva Stomatol
1992;41:203-7.
Published
2020-06-19